Program
Adalimumab
Also written as “adalimumab”, “MSB11022” and “M923”.
Its studies are mostly in Arthritis, Rheumatoid · Psoriasis · Crohn Disease · Colitis, Ulcerative · Hidradenitis Suppurativa, led by 17 companies.
Drug pageAdalimumab: every studyMany companies study it; this page follows only the 149 they lead. All 319 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Abbott | 620 open or running | phase 4since Sep 13, 2005 | Nov 1, 2002 | none ahead |
| AbbVieits history only | 543 open or running | phase 4since May 25, 2010 | Sep 13, 2005 | Sep 2027phase 2 · NCT06257875 |
| Alvotech Swissits history only | 60 open or running | phase 3since Feb 5, 2019 | Jun 8, 2018 | none ahead |
| Johnson & Johnsonits history only | 50 open or running | phase 3since Dec 18, 2013 | Dec 18, 2013 | none ahead |
| Fresenius Kabiits history only | 40 open or running | phase 3since Jan 17, 2016 | Jan 17, 2016 | none ahead |
| Biocadits history only | 30 open or running | phase 3since Mar 31, 2016 | Mar 16, 2015 | none ahead |
| Cinnagenits history only | 20 open or running | phase 3since May 24, 2017 | May 24, 2017 | none ahead |
| Sino Biopharmaceuticalits history only | 22 open or running | phase 4since Apr 8, 2026 | Apr 8, 2026 | Apr 2028phase 4 · NCT07529925 |
| Takedaits history only | 20 open or running | phase 4since May 5, 2016 | Mar 15, 2015 | none ahead |
| Viatrisits history only | 20 open or running | phase 3since Nov 9, 2015 | Jun 3, 2015 | none ahead |
| care-arthritis-ltdits history only | 10 open or running | phase 2since Feb 24, 2015 | Feb 24, 2015 | none ahead |
| Celltrionits history only | 10 open or running | phase 3since Sep 18, 2019 | Sep 18, 2019 | none ahead |
| LG Chemits history only | 10 open or running | phase 1since Jul 30, 2014 | Jul 30, 2014 | none ahead |
| mabscale-llcits history only | 11 open or running | phase 3since Jul 5, 2023 | Jul 5, 2023 | none ahead |
| National Resilienceits history only | 10 open or running | phase 3since Jan 10, 2021 | Jan 10, 2021 | none ahead |
| prestige-biopharma-limitedits history only | 11 open or running | phase 1since Oct 1, 2021 | Oct 1, 2021 | Jun 2027phase 1 · NCT05108259 |
| Samsung Bioepisits history only | 10 open or running | phase 1since Aug 13, 2020 | Aug 13, 2020 | none ahead |
Also a collaborator on its studies: Merck KGaA, Darmstadt, Germany, Mylan, Pharm-Olam, PPD DEVELOPMENT, LP, PRA Health Sciences, IST GmbH, Germany, Parexel, Pivotal S.L., GlaxoSmithKline, Regeneron Pharmaceuticals, Eisai and Abbott Japan.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Abbott only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). An open circle marks the day WHO proposed its name. Dates ahead are the sponsors’ estimates.
Before these, 37 studies since Mar 3, 2003.
- Oct 1, 2007Phase 3 study in Arthritis, RheumatoidNCT00538902 · 302 enrolled · China
- Dec 1, 2007Phase 3 study in PsoriasisNCT00566722 · 152 enrolled · United States, Canada
- Jan 10, 2008Phase 3 study in Arthritis, RheumatoidNCT00603993 · 88 enrolled · Japan
- Mar 25, 20085 phase 2 studiesNCT00645892, NCT00646386, NCT00646191 and 2 more
- Mar 26, 20085 phase 3 studiesNCT00646178, NCT00647491, NCT00647400 and 2 more
- Mar 28, 2008Phase 4 study in Arthritis, RheumatoidNCT00649922 · 226 enrolled
- Apr 24, 2008Phase 3 study in Spondylitis, AnkylosingNCT00667355 · 41 enrolled · Japan
- Jun 2, 2008Phase 3 study in Arthritis, JuvenileNCT00690573 · 25 enrolled · Japan
- Aug 13, 2008Phase 4 study in PsoriasisNCT00735787 · 81 enrolled · United States, Canada
- Sep 25, 2008Phase 4 study in Arthritis, RheumatoidNCT00761514 · 14 enrolled · Puerto Rico
- Mar 26, 2009Phase 3 study in Arthritis, RheumatoidNCT00870467 · 334 enrolled · Japan
- Apr 30, 2009Phase 2 study in Hidradenitis SuppurativaNCT00918255 · 154 enrolled · United States, Denmark, Germany and more
- Feb 5, 20102 phase 3 studiesNCT01114880, NCT01070303
- Oct 28, 2010Phase 3 study in Arthritis, RheumatoidNCT01231321 · 100 enrolled · Russian Federation
- Dec 9, 2017Named adalimumabINNProposed as its International Nonproprietary Name in WHO's List 118 · before, MSB11022, M923
TargetBeta
“TNF-alpha inhibitor”ChEMBL 37, by rule
Other programs on TNF
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Brentuximab Vedotinrule | Pfizer | phase 4 | 37 |
| CHS-1420rule | nanjing-king-friend-biochemical-pharmaceutical-co-ltd | phase 3 | 2 |
| brivekimig | Sanofi | phase 2 | 6 |
| Hadlimarule | biora-therapeutics-inc | phase 1 | 1 |
Studies
The newest 60 of 62 Abbott leads. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT01231321Arthritis, Rheumatoid · Russian Federation | 3 | Completed | Feb 2010 | 100 |
| NCT01070303Crohn Disease · United States | 3 | Completed | Dec 2008 | 177 |
| NCT01114880Spondylitis, Ankylosing · China | 3 | Completed | Sep 2010 | 344 |
| NCT00918255Hidradenitis Suppurativa · United States, Denmark, Germany and more | 2 | Completed | Mar 2010 | 154 |
| NCT00870467Arthritis, Rheumatoid · Japan | 3 | Completed | Mar 2011 | 334 |
| NCT00761514Arthritis, Rheumatoid · Puerto Rico | 4 | Terminated | Aug 2008 | 14 |
| NCT00735787Psoriasis · United States, Canada | 4 | Completed | Sep 2009 | 81 |
| NCT00690573Arthritis, Juvenile · Japan | 3 | Completed | Mar 2010 | 25 |
| NCT00667355Spondylitis, Ankylosing · Japan | 3 | Completed | May 2009 | 41 |
| NCT00649922Arthritis, Rheumatoid | 4 | Completed | Dec 2004 | 226 |
| NCT00647920Arthritis, Rheumatoid · Taiwan | 3 | Completed | Apr 2005 | 47 |
| NCT00647491Arthritis, Rheumatoid · Japan | 3 | Completed | Jun 2005 | 352 |
| NCT00647400Psoriasis · Japan | 3 | Completed | Sep 2007 | 147 |
| NCT00647270Arthritis, Rheumatoid · United States, Australia, Canada and more | 3 | Completed | Apr 2009 | 420 |
| NCT00646386Arthritis | 2 | Completed | Apr 2004 | 315 |
| NCT00646191Psoriasis | 2 | Completed | Jun 2004 | 137 |
| NCT00646178Arthritis | 3 | Completed | Mar 2004 | 102 |
| NCT00645905Psoriasis | 2 | Completed | Mar 2005 | 148 |
| NCT00645814Psoriasis | 2 | Completed | Sep 2003 | 148 |
| NCT00645892Psoriasis | 2 | Completed | Sep 2004 | 32 |
| NCT00603993Arthritis, Rheumatoid · Japan | 3 | Completed | Nov 2006 | 88 |
| NCT00566722Psoriasis · United States, Canada | 3 | Completed | Apr 2009 | 152 |
| NCT00538902Arthritis, Rheumatoid · China | 3 | Completed | Jul 2008 | 302 |
| NCT00513370Psoriasis · Canada | 3 | Completed | Sep 2008 | 203 |
| NCT00512863Asthma | 2 | Withdrawn | 272 | |
| NCT00478660Spondylitis, Ankylosing · Austria, Belgium, Denmark and more | 3 | Completed | 1,250 | |
| NCT00448383Arthritis, Rheumatoid | 3 | Completed | Nov 2004 | 6,610 |
| NCT00445939Crohn Disease · Japan | 3 | Completed | Dec 2007 | 90 |
| NCT00445432Crohn Disease · Japan | 3 | Completed | Mar 2009 | 82 |
| NCT00427921Crohn Disease · United States | 3 | Completed | Jan 2008 | 304 |
| NCT00427362Arthritis, Psoriatic | 3 | Completed | May 2007 | 127 |
| NCT00420927Arthritis, Rheumatoid · United States, Argentina, Australia and more | 4 | Completed | Jul 2010 | 1,032 |
| NCT00409682Crohn Disease · United States, Belgium, Canada and more | 3 | Completed | May 2010 | 192 |
| NCT00409617Crohn Disease · Austria, Belgium, Czech Republic and more | 3 | Completed | Jul 2008 | 945 |
| NCT00408629Colitis, Ulcerative · United States, Argentina, Australia and more | 3 | Completed | Mar 2010 | 518 |
| NCT00385736Colitis, Ulcerative · United States, Austria, Belgium and more | 3 | Completed | Apr 2009 | 576 |
| NCT00348283Crohn Disease · United States, Austria, Belgium and more | 3 | Completed | Sep 2008 | 135 |
| NCT00338650Crohn Disease · United States | 3 | Completed | 1,000 | |
| NCT00237887Psoriasis | 3 | Completed | 1,212 | |
| NCT00235885Arthritis, Psoriatic · United States | 3 | Completed | 445 | |
| NCT00235872Arthritis, Rheumatoid · Japan | 3 | Completed | Jul 2006 | 309 |
| NCT00235859Arthritis, Rheumatoid | 3 | Completed | 128 | |
| NCT00235833Arthritis, Rheumatoid · Japan | 2 | Completed | Oct 2004 | 25 |
| NCT00235820Psoriasis · United States | 3 | Completed | May 2006 | 271 |
| NCT00234936Arthritis, Rheumatoid | 3 | Completed | 200 | |
| NCT00195819Spondylitis, Ankylosing · Canada | 3 | Completed | Oct 2004 | 82 |
| NCT00234897Arthritis, Rheumatoid · United States | 4 | Completed | 1,938 | |
| NCT00234845Arthritis, Rheumatoid · United States | 3 | Completed | 148 | |
| NCT00233571Arthritis, Rheumatoid | 3 | Completed | Jun 2006 | 796 |
| NCT00233558Arthritis, Rheumatoid · United States | 4 | Terminated | 160 | |
| NCT00195715Crohn Disease · United States, Australia, Belgium and more | 3 | Completed | Mar 2006 | 777 |
| NCT00195702Arthritis, Rheumatoid · United States, Canada | 3 | Completed | Sep 2002 | 619 |
| NCT00195689Arthritis, Psoriatic · United States | 3 | Completed | 400 | |
| NCT00195676Psoriasis · United States, Austria, Belgium and more | 3 | Completed | Oct 2009 | 1,469 |
| NCT00195650Arthritis, Rheumatoid · United States, Canada | 3 | Completed | May 2011 | 846 |
| NCT00105300Crohn Disease · United States, Belgium, Canada and more | 3 | Completed | 300 | |
| NCT00085644Spondylitis, Ankylosing · United States | 3 | Completed | Dec 2004 | 315 |
| NCT00077779Crohn Disease · United States | 3 | Completed | 854 | |
| NCT00055523Crohn Disease · United States | 2 | Completed | 300 | |
| NCT00055497Crohn Disease · United States | 3 | Completed | Jan 2005 | 276 |
How it is read
Names in the registry
- “Adalimumab”, 69 entries
- “adalimumab”, 63 entries
- “MSB11022”, 3 entries
- “M923”, 3 entries
- “Humira (adalimumab)”, 3 entries
Codes read as this program: AVT02.
Conditions, from the studies’ own filings
- Arthritis, Rheumatoid, 45 studies
- Psoriasis, 25 studies
- Crohn Disease, 23 studies
- Colitis, Ulcerative, 9 studies
- Hidradenitis Suppurativa, 6 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.